SRPT
Sarepta Therapeutics Inc
17.30$
-1.0%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -34.6% | -13.8% | -58.5% | 4.1% | -15.1% | 14.0% | -78.3% | 42.8% | -3.7% | 29.6% | -27.7% | -1.4% | -4.6% | |
| 3.3% | 2.9% | 2.1% | 2.4% | 2.1% | 1.6% | 1.3% | 1.8% | 4.6% | 1.2% | 1.4% | 5.2% | 2.8% | |
| 14.5% | 11.5% | 9.8% | 13.9% | 9.3% | 7.5% | 5.6% | 6.1% | 3.7% | 6.8% | 4.0% | 13.4% | 6.5% | |
| -46.6% | -37.9% | -79.7% | -12.5% | -46.4% | -19.0% | -37.8% | 8.1% | -7.3% | 76.7% | -80.2% | -110.4% | -36.4% | |
| 12.3% | 4.8% | 10.3% | 8.0% | 8.0% | 5.8% | 6.2% | 5.2% | 7.1% | 1.3% | 0.4% | 0.7% | 2.0% | |
| -63.5% | -16.2% | 52.9% | -27.1% | -27.6% | 116.1% | -39.1% | 5.3% | 58.2% | 21.7% | -18.4% | -56.8% | -1.7% | |
| – | – | – | – | – | – | – | -4.1% | 0.0% | 0.0% | – | – | – | |
| – | – | – | – | – | – | -0.4% | 0.0% | -31.0% | -7.9% | 0.0% | 0.0% | -8.1% | |
| 4.6% | 0.5% | 5.4% | 11.0% | 2.9% | 7.4% | 1.7% | -3.9% | -29.5% | -8.9% | 0.0% | 0.1% | -7.9% | |
| -93.4% | -29.5% | -0.3% | -12.0% | -39.8% | 137.5% | -115.7% | 44.1% | 25.0% | 42.5% | -46.1% | -58.1% | -14.3% | |
| -46.9% | -18.6% | -68.8% | -3.9% | -23.1% | 8.2% | -84.5% | 37.5% | -10.7% | 28.3% | -28.2% | -2.1% | -6.7% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.